CDKN2B-AS1 and esophageal squamous cell carcinoma: However, accumulating evidence indicates that lncRNA ANRIL could increase the growth and migration and invasion abilities of cancer cells by positively regulating the TGF-β1/Smad signaling pathway in oral squamous cell carcinoma, thyroid cancer, and esophageal squamous cell carcinoma [34–36].